Lateral Flow Assay for Antineoplastic Drug Surface Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting antineoplastic drug contamination on work site surfaces are cumbersome, time-consuming, and expensive, requiring specialized expertise and delaying cleanup due to the lack of quick and inexpensive detection methods.
Innovation Solution
A lateral flow assay method using a wetting solution and solid matrix to release and absorb antineoplastic drugs, followed by a lateral flow assay device with a conjugate pad, porous support, and wicking pad for capillary flow, allowing for rapid detection of antineoplastic drug contamination on surfaces.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional analytical methods are used to detect antineoplastic drug contamination, then measurement precision is improved, but loss of time and device complexity increase
Solution Approach 1:
The invention extracts the detection function from complex centralized laboratory analytical methods and implements it in a simplified portable lateral flow device that can be used at the point of need, eliminating the need for sample shipment and lengthy laboratory processing while maintaining detection capability
Solution Approach 2:
The invention creates a simplified copy of the analytical detection function using lateral flow technology with antibody-antigen binding, which replicates the essential detection capability of complex analytical methods but in a format that is rapid, portable, and does not require sophisticated laboratory infrastructure
2Measurement precision
If conventional analytical methods are used to detect antineoplastic drug contamination, then measurement precision is improved, but device complexity and cost increase
Solution Approach 1:
The invention employs disposable lateral flow test strips that are inexpensive to manufacture and use, eliminating the need for expensive, complex analytical instrumentation and specialized laboratory equipment while providing sufficient detection accuracy for the application
Solution Approach 2:
The invention replaces complex mechanical and chemical analytical systems with a simplified immunological assay based on antibody-antigen binding and capillary flow, eliminating the need for sophisticated instrumentation, trained operators, and complex sample preparation procedures
3Loss of time
If rapid detection methods are implemented, then loss of time is reduced, but measurement precision may worsen
Solution Approach 1:
The invention incorporates pre-coated antibody conjugates and optimized sample application procedures that enable rapid detection within minutes while maintaining precision through pre-established binding conditions and control mechanisms built into the lateral flow device
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, cost-effective, and straightforward detection of antineoplastic drug contamination on surfaces, facilitating quick cleanup and reducing exposure risks for healthcare workers.
Implementation Method 1
providing a wetting solution compatible with the antineoplastic drug and formulated to promote release of the drug from the surface to be assayed
Implementation Method 2
providing a wetting solution compatible with the antineoplastic drug and formulated to promote release of the drug from the surface to be assayed
Implementation Method 3
providing a solid matrix for reversible absorption of the antineoplastic drug; contacting the solid matrix with the wetting solution
Implementation Method 4
the solid or semi-solid porous support adjacent a wicking pad that promotes the capillary flow of the fluid test sample along a flow path
Data Source
AI summary
Methods, kits and devices for detecting antineoplastic drug contamination of a surface are provided according to aspects of the present invention. According to aspects of the invention, methods for detecting antineoplastic drug contamination of a surface include providing a wetting solution compatible with the antineoplastic drug and formulated to promote release of the drug from the surface to be assayed; providing a solid matrix for reversible absorption of the antineoplastic drug; contacting the solid matrix with the wetting solution, generating an assay matrix; contacting the assay matrix and the surface, generating a surface sample; contacting the surface sample with a volume of wetting solution, generating a fluid test sample; and quantifying the antineoplastic drug in the fluid test sample by lateral flow assay to produce an assay result, thereby detecting antineoplastic drug contamination of the surface.